12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 11.1% to $1.3 during Tuesday’s after-market session. The company’s market…
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 23.3% to $0.57 during Monday’s after-market session. The market…
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
Gossamer Bio partners with Chiesi Farmaceutici to develop and market seralutinib globally, targeting pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Gossamer Bio Secures $160M Partnership with Chiesi Group to Accelerate Development of Pulmonary Hypertension Treatment, $486M Potential for Seralutinib Collaboration
Gossamer Bio, Inc. ("Gossamer") (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, and
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 51.8% to $1.29 during Thursday’s after-market session. The company’s market cap…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Longeveron (NASDAQ:LGVN) stock rose 48.6% to $3.27 during Friday’s after-market session. The company’s market cap stands at…
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares rose 138.8% to $0.82 during Tuesday’s regular session. The market value of their…
HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: Here’s What You Need To Know
HC Wainwright & Co. has decided to maintain its Buy rating of Gossamer Bio (NASDAQ:GOSS) and raise its…
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Invivyd (NASDAQ:IVVD) stock moved upwards by 157.7% to $4.2 during Monday’s regular session. The market value of…